Synthesis and antitubercular activities of bis-glycosylated diamino alcohols

Bioorganic and Medicinal Chemistry

Volumn 13, Issue 19, 2005, Pages 5668-5679

  Tripathi, R P ^a   Tiwari, V K ^a   Tewari, N ^a   Katiyar, D ^a   Saxena, N ^a   Sinha, S ^a   Gaikwad, A ^a   Srivastava, A ^a   Chaturvedi, V ^a   Manju, Y K ^a   Srivastava, R ^a   Srivastava, B S ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Glycosyl amines; Glycosyl amino alcohols; Lithium aluminium hydride; MDR tuberculosis; Tuberculosis

Indexed keywords

ALUMINUM DERIVATIVE; AMINOALCOHOL; DIAMINE DERIVATIVE; ESTER DERIVATIVE; ETHAMBUTOL; N 1,N 10 BIS(3 O BENZYL 5 HYDROXYETHYL 5 DEOXY 1,2 O ISOPROPYLIDENE ALPHA DEXTRO XYLOFURANOS 5 YL) 1,10 DIAMINODECANE; N 1,N 10 BIS(6 CARBETHOXYMETHYL 6 DEOXY 1,2:3,4 DI O ISOPROPYLIDENE ALPHA DEXTRO GALACTOPYRANOS 6 YL) 1,10 DIAMINODECANE; N 1,N 10 BIS(6 DEOXY 6 HYDROXYETHYL 1,2:3,4 DI O ISOPROPYLIDENE ALPHA DEXTRO GALACTOPYRANOS 6 YL) 1,10 DIAMINODECANE; N 1,N 12 BIS(3 O BENZYL 5 HYDROXYETHYL 5 DEOXY 1,2 O ISOPROPYLIDENE ALPHA DEXTRO XYLOFURANOS 5 YL) 1,12 DIAMINODODECANE; N 1,N 12 BIS(6 CARBETHOXYMETHYL 6 DEOXY 1,2:3,4 DI O ISOPROPYLIDENE ALPHA DEXTRO GALACTOPYRANOS 6 YL) 1,12 DIAMINODODECANE; N 1,N 12 BIS(DEOXY 6 HYDROXYETHYL 1,2:3,4 DI O ISOPROPYLIDENE ALPHA DEXTRO GALACTOPYRANOS 6 YL) 1,12 DIAMINODODECANE; N 1,N 3 BIS(3 O BENZYL 5 HYDROXYETHYL 5 DEOXY 1,2 O ISOPROPYLIDENE ALPHA DEXTRO XYLOFURANOS 5 YL) 1,3 DIAMINOPROPANE; N 1,N 4 BIS(CARBETHOXYMETHYL 6 DEOXY 1,2:3,4 DI O ISOPROPYLIDENE ALPHA DEXTRO GALACTOPYRANOS 6 YL) 1,4 DIAMINOBUTANE; N 1,N 4 BIS(DEOXY 6 HYDROXYETHYL 1,2:3,4 DI O ISOPROPYLIDENE ALPHA DEXTRO GALACTOPYRANOS 6 YL) 1,4 DIAMINOBUTANE; N 1,N 7 BIS(3 O BENZYL 5 HYDROXYETHYL 5 DEOXY 1,2 O ISOPROPYLIDENE ALPHA DEXTRO XYLOFURANOS 5 YL) 1,7 DIAMINOHEPTANE; N 1,N 7 BIS(6 CARBETHOXYMETHYL 6 DEOXY 1,2:3,4 DI O ISOPROPYLIDENE ALPHA DEXTRO GALACTOPYRANOS 6 YL) 1,7 DIAMINOHEPTANE; N 1,N 7 BIS(6 DEOXY 6 HYDROXYETHYL 1,2:3,4 DI O ISOPROPYLIDENE ALPHA DEXTRO GALACTOPYRANOS 6 YL) 1,7 DIAMINOHEPTANE; N 1,N 8 BIS(3 O BENZYL 5 CARBETHOXYMETHYL 5 DEOXY 1,2 O ISOPROPYLIDENE ALPHA DEXTRO XYLOFURANOS 5 YL) 1,8 DIAMINOOCTANE; N 1,N 8 BIS(3 O BENZYL 5 HYDROXYMETHYL 5 DEOXY 1,2 O ISOPROPYLIDENE ALPHA DEXTRO XYLOFURANOS 5 YL) 1,8 DIAMINOOCTANE; N 1,N 8 BIS(6 CARBETHOXYMETHYL 6 DEOXY 1,2:3,4 DI O ISOPROPYLIDENE ALPHA DEXTRO GALACTOPYRANOS 6 YL) 1,8 DIAMINOOCTANE; N 1,N 8 BIS(6 DEOXY 6 HYDROXYETHYL 1,2:3,4 DI O ISOPROPYLIDENE ALPHA DEXTRO GALACTOPYRANOS 6 YL) 1,8 DIAMINOOCTANE; N 1,N 9 BIS(3 O BENZYL 5 CARBETHOXYMETHYL 5 DEOXY 1,2 O ISOPROPYLIDENE ALPHA DEXTRO XYLOFURANOS 5 YL) 1,9 DIAMINONONANE; N 1,N 9 BIS(3 O BENZYL 5 HYDROXYETHYL 5 DEOXY 1,2 O ISOPROPYLIDENE ALPHA DEXTRO XYLOFURANOS 5 YL) 1,9 DIAMINONONANE; N 1,N 9 BIS(6 CARBETHOXYMETHYL 6 DEOXY 1,2:3,4 DI O ISOPROPYLIDENE ALPHA DEXTRO GALACTOPYRANOS 6 YL) 1,8 DIAMINONONANE; N 1,N 9 BIS(6 DEOXY 6 HYDROXYETHYL 1,2:3,4 DI O ISOPROPYLIDENE ALPHA DEXTRO GALACTOPYRANOS 6 YL) 1,9 DIAMINONONANE; OFLOXACIN; RIFAMPICIN; UNCLASSIFIED DRUG;

ADDITION REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG SYNTHESIS; GLYCOSYLATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REDUCTION;

AMINO ALCOHOLS; ANIMALS; ANTITUBERCULAR AGENTS; DISEASE MODELS, ANIMAL; GLYCOSYLATION; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR CONFORMATION; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; STRUCTURE-ACTIVITY RELATIONSHIP;

MYCOBACTERIUM TUBERCULOSIS;

EID: 23944523861     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2005.05.021     Document Type: Article

References (38)

1. E. Stokstad Science 287 2000 2391
2. WHO Global tuberculoasis programme-Tuberculosis Fact Sheet, 2002. World Health Organisation. Global Tuberculosis Control, WHO Report 2001.
3. World Health Organisation, Geneva, Switzerland, WHO/CDS/TB/2001, 287. http://www.who.int/mediacentre/factsheets/who104/en/index.html.
4. N. Mooran Nat. Med. 2 1996 377
5. C. Dye, S. Scheele, P. Dolin, V. Pathania, and M.C. Raviglione J. Am. Med. Assoc. 282 1999 677
6. M.C. Raviglione, D.E. Snider Jr., and A. Kochi J. Am. Med. Assoc. 273 1995 220 226
7. P. Farmer, J. Bayona, M. Beccera, J. Henry, C. Furin, H. Hiarr, J.Y. Kim, C. Mimic, E. Nardell, and S. Shin Int. J. Tuberc. Lung 2 1998 869 876
8. S.W. Dooley, W.R. Jarvis, W.J. Martone, and D.E. Snyder Jr. Ann. Intern. Med. 117 1992 257 259
9. I. Chopra, and P. Brennan Tubercl. Lung Dis. 78 1988 89 98
10. J.S. Blanchard Annu. Rev. Biochem. 65 1996 215 239
11. D. Mitchison, and P. Nunn Am. Rev. Resp. Dis. 133 1986 423 430
12. D.B. Young, and T.R. Garbe Res. Microbiol. 142 1991 55 65
13. N.D. Connel, and H. Nikaido B.R. Bloom Membrane Permeability and Transport in Mycobacterium tuberculosis: Pathogenesis, Protection and Control 1994 American Society for Microbiology Washington, DC 233
14. P.J. Brennan Annu. Rev. Biochem. 64 1995 29 63
15. R.P. Tripathi, N. Tewari, N. Dwivedi, and V.K. Tiwari Med. Res. Rev. 25 2005 93 131
16. L. Kremmer, L.G. Dover, C. Morehouse, P. Hitchin, M. Everett, H.R. Morris, A. Dell, P.J. Brernnan, and M.R. McNeil J. Biol. Chem. 276 2001 26430 26440
17. N.E. Caceres, N.B. Harris, J.F. Wellehan, Z. Feng, V. Kapur, and R.G. Barletta J. Bacetriol. 179 1997 5046 5055
18. J.T. Belisle, V.D. Visaa, T. Sievert, K. Takayama, P.J. Brennan, and G.S. Besra Science 276 1997 1420 1422
19. K. Mikusawa, T. Yagi, R. Stern, M.R. McNeil, G.S. Besra, D.C. Crick, and P.J. Brennan J. Biol. Chem. 275 2000 33890 33897
20. R.J. Stern, T.Y. Lee, T.J. Lee, W. Yan, M.S. Scherman, V.D. Visa, S.K. Kim, B.L. Wanner, and M.R. McNeil Microbiology 145 1999 663 671
21. J.A. Maddry, N. Bansal, L.E. Bermudez, R.N. Comber, I.M. Orme, W.J. Suling, L.N. Willson, and R.C. Reynolds Bioorg. Med. Chem. Lett. 8 1998 237 342
22. R.C. Reynolds, N. Bansal, J. Rose, J. Friedrich, W.J. Suiling, and J.A. Maddry Carbohydr. Res. 317 1999 164 179
23. A.K. Pathak, V. Pathak, A.M. Joseph, W.J. Suling, L.N. Wilson, and R.C. Reynolds Bioorg. Med. Chem. 9 2001 3145
24. X. Wen, D.C. Crick, P.J. Brennan, and P.G. Hutlin Bioorg. Med. Chem. 11 2003 3579
25. R.P. Tripathi, R. Tripathi, V.K. Tiwari, L. Bala, S. Sinha, A. Srivastava, R. Srivastava, and B.S. Srivastava Eur. J. Med. Chem. 37 2002 773 781
26. D. Katiyar, V.K. Tiwari, N. Tewari, S.S. Verma, S. Sinha, A. Gaikwad, A. Srivastava, V. Chaturvedi, R. Srivastava, B.S. Srivastava, and R.P. Tripathi Eur. J. Med. Chem. 40 2005 351 360
27. N. Tewari, V.K. Tiwari, R.P. Tripathi, A. Gaikwad, S. Sinha, P.K. Shukla, R. Srivastava, and B.S. Srivastava Bioorg. Med. Chem. Lett. 12 2004 329 332
28. J.P. Mackay, U. Gerhard, D.A. Beauregard, D.M. Williams, M.S. Westwell, and S. Searle J. Am. Chem. Soc. 116 1994 4581
29. K. Michael, H. Wang, and Y. Tor Bioorganic Med. Chem. 7 1999 1361
30. Koeda, T.; Umemura, K.;Yokota, M.; Umemura, H.; Hooper, R. In Aminoglycoside Antibiotics, Umezawa, H., Hooper, I.R., Eds.; Springer-Verlag: Berlin, 1982, Vol. 62, pp. 293-256.
31. U. Gerhard, J.P. Mackay, R.A. Maplestone, and D.H. Williams J. Am. Chem. 115 1993 232
32. G.H. Caughey, W.W. Raymond, E. Bucci, R.J. Lamberdy, and R.R. Tidwell J. Pharmacol. Exp. Ther. 264 1993 676
33. M. Garcia, X.del. Rio, S. Silvestre, M. Rubiralta, E. Lozoya, V. Segarra, D. Fernandez, M. Miralpeix, M. Aparici, and A. Diez Org. Biomol. Chem. 2 2004 1633
34. V.K. Tiwari, N. Tewari, D. Katiyar, R.P. Tripathi, K. Arora, S. Gupta, A.K. Srivastava, M.A. Khan, and P.K. Murthy Bioorg. Med. Chem 11 2003 1789 1800
35. D. Katiyar, R.C. Mishra, and R.P. Tripathi J. Carbohydr. Chem. 23 2004 49 70
36. L.A. Collins, and S.G. Franzblan Antimicrob. Agents Chemother. 41 1997 1004 1009
37. H. Saito, H. Tomioka, K. Sato, M. Emori, T. Yamane, K. Yamashita, K. Hosol, and T. Hidaka Antimicrob. Agents Chemother. 35 1991 542 547
38. D. Katiyar, V.K. Tiwari, R.P. Tripathi, A. Srivastava, V. Chaturvedi, R. Srivastava, and B.S. Srivastava Bioorg. Med. Chem. 11 2003 4369